GlassScriptPhysician profile
Lawrence S Mactavish
NPI 1104858885
$40,644.13
in general payments reported to CMS, 2019-2025
39 companies · $2,110 in 2025
The $2,110 reported for 2025 was more than what 91% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $875 · 2021: $279 · 2022: $7,910 · 2023: $1,894 · 2024: $27K · 2025: $2,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $27K · Food and Beverage: $3,417 · Travel and Lodging: $1,301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $26,664.00 |
| Food and Beverage | $3,416.68 |
| Travel and Lodging | $1,301.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $26,664.00 | 2024 | |
| Triad Life Sciences INC. | $7,697.44 | 2022 | |
| Treace Medical Concepts, INC. | $1,666.97 | 2023-2025 | |
| Trimed, INC. | $1,227.11 | 2022-2025 | |
| Sanara Medtech INC. | $794.28 | 2020-2022 | |
| Stryker Corporation | $741.83 | 2019-2025 | Augment Injectable |
| Organogenesis INC. | $201.74 | 2020-2025 | Affinity |
| Averitas Pharma INC. | $173.53 | 2023-2025 | Qutenza |
| Reddress USA, INC. | $165.51 | 2024-2025 | Actigraft |
| Smith+Nephew, INC. | $144.02 | 2023-2025 | Renasys Touch, Collagenase Santyl, Bone Anchors With Arthroscopic Delivery System |
| Ossio INC | $126.08 | 2024 | |
| Mimedx Group, INC. | $101.61 | 2024-2025 | |
| Medinc of Texas | $87.09 | 2025 | |
| Melinta Therapeutics, LLC | $83.69 | 2019 | |
| Reprise Biomedical, INC. | $69.71 | 2024-2025 | Miro3d |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $57.84 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Osiris Therapeutics INC. | $55.16 | 2019 | |
| Tactile Systems Technology INC | $46.64 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Nevro Corp. | $42.98 | 2023 | Senza |
| Davol INC. | $39.31 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $34.39 | 2021-2025 | Exparel |
| Ets Wound Care LLC | $33.04 | 2024 | Mirragen Advanced Wound Matrix |
| Abbott Laboratories | $32.97 | 2023-2024 | Eterna, Octrode |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $32.47 | 2020-2022 | |
| Amgen INC. | $32.19 | 2024-2025 | Krystexxa |
| Bioventus LLC | $30.28 | 2025 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $29.27 | 2023 | Krystexxa |
| Abbvie INC. | $28.77 | 2023 | |
| Lifenet Health | $26.94 | 2025 | Theragenesis Wound Matrix |
| Dynasplint Systems INC. | $24.15 | 2023 | Dynasplint |
| Wright Medical Technology, INC. | $23.24 | 2019 | |
| Aroa Biosurgery Incorporated | $20.86 | 2025 | |
| Innovation Technologies INC | $19.32 | 2024 | Irrisept |
| Fidia Pharma USA INC. | $18.35 | 2025 | |
| Grt US Holding, INC. | $17.36 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.69 | 2022 | |
| Kerecis Limited | $14.18 | 2022 | |
| Paratek Pharmaceuticals, INC. | $13.90 | 2022 | |
| Merck Sharp & Dohme LLC | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Mactavish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.